鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/11 | 2,878 | 2,895 | 2,876 | 2,879 | +14 | +0.5% | 17,700 |
2023/01/10 | 2,855 | 2,874 | 2,845 | 2,865 | +13 | +0.5% | 18,000 |
2023/01/06 | 2,835 | 2,859 | 2,813 | 2,852 | +2 | +0.1% | 34,600 |
2023/01/05 | 2,900 | 2,950 | 2,834 | 2,850 | -48 | -1.7% | 33,100 |
2023/01/04 | 2,900 | 2,913 | 2,874 | 2,898 | -16 | -0.5% | 37,200 |
2022/12/30 | 2,913 | 2,965 | 2,912 | 2,914 | -3 | -0.1% | 29,000 |
2022/12/29 | 2,841 | 2,920 | 2,839 | 2,917 | +52 | +1.8% | 37,300 |
2022/12/28 | 2,858 | 2,885 | 2,849 | 2,865 | -4 | -0.1% | 42,800 |
2022/12/27 | 2,881 | 2,888 | 2,867 | 2,869 | +10 | +0.3% | 11,500 |
2022/12/26 | 2,867 | 2,868 | 2,842 | 2,859 | -5 | -0.2% | 12,300 |
2022/12/23 | 2,858 | 2,876 | 2,851 | 2,864 | -1 | ±0% | 13,700 |
2022/12/22 | 2,880 | 2,880 | 2,852 | 2,865 | ±0 | ±0% | 18,300 |
2022/12/21 | 2,845 | 2,871 | 2,820 | 2,865 | +9 | +0.3% | 20,900 |
2022/12/20 | 2,902 | 2,921 | 2,851 | 2,856 | -34 | -1.2% | 37,100 |
2022/12/19 | 2,874 | 2,901 | 2,871 | 2,890 | -18 | -0.6% | 20,200 |
2022/12/16 | 2,899 | 2,913 | 2,888 | 2,908 | +5 | +0.2% | 38,500 |
2022/12/15 | 2,890 | 2,931 | 2,884 | 2,903 | +25 | +0.9% | 25,000 |
2022/12/14 | 2,874 | 2,895 | 2,874 | 2,878 | +4 | +0.1% | 9,500 |
2022/12/13 | 2,867 | 2,880 | 2,866 | 2,874 | +24 | +0.8% | 12,600 |
2022/12/12 | 2,840 | 2,862 | 2,821 | 2,850 | -9 | -0.3% | 16,600 |
2022/12/09 | 2,872 | 2,872 | 2,829 | 2,859 | +22 | +0.8% | 34,100 |
2022/12/08 | 2,800 | 2,839 | 2,800 | 2,837 | +31 | +1.1% | 25,200 |
2022/12/07 | 2,774 | 2,810 | 2,772 | 2,806 | +35 | +1.3% | 17,500 |
2022/12/06 | 2,810 | 2,824 | 2,771 | 2,771 | -39 | -1.4% | 19,500 |
2022/12/05 | 2,844 | 2,844 | 2,779 | 2,810 | -18 | -0.6% | 36,300 |
2022/12/02 | 2,882 | 2,882 | 2,818 | 2,828 | -44 | -1.5% | 48,900 |
2022/12/01 | 2,902 | 2,917 | 2,864 | 2,872 | -30 | -1% | 28,900 |
2022/11/30 | 2,925 | 2,925 | 2,895 | 2,902 | -19 | -0.7% | 48,600 |
2022/11/29 | 2,915 | 2,935 | 2,885 | 2,921 | -1 | ±0% | 24,300 |
2022/11/28 | 2,952 | 2,958 | 2,922 | 2,922 | -44 | -1.5% | 11,300 |
2022/11/25 | 2,974 | 2,993 | 2,958 | 2,966 | -11 | -0.4% | 26,500 |
2022/11/24 | 2,991 | 3,000 | 2,970 | 2,977 | -13 | -0.4% | 27,700 |
2022/11/22 | 2,960 | 2,995 | 2,960 | 2,990 | +40 | +1.4% | 46,700 |
2022/11/21 | 2,931 | 2,965 | 2,921 | 2,950 | +19 | +0.6% | 27,000 |
2022/11/18 | 2,915 | 2,945 | 2,915 | 2,931 | +23 | +0.8% | 27,500 |
2022/11/17 | 2,875 | 2,929 | 2,875 | 2,908 | +13 | +0.4% | 15,200 |
2022/11/16 | 2,898 | 2,902 | 2,871 | 2,895 | -7 | -0.2% | 23,100 |
2022/11/15 | 2,896 | 2,924 | 2,896 | 2,902 | +6 | +0.2% | 20,300 |
2022/11/14 | 2,890 | 2,900 | 2,881 | 2,896 | -16 | -0.5% | 13,100 |
2022/11/11 | 2,929 | 2,929 | 2,886 | 2,912 | +31 | +1.1% | 18,800 |
2022/11/10 | 2,907 | 2,907 | 2,873 | 2,881 | -20 | -0.7% | 20,300 |
2022/11/09 | 2,900 | 2,914 | 2,888 | 2,901 | -3 | -0.1% | 20,600 |
2022/11/08 | 2,894 | 2,929 | 2,884 | 2,904 | -1 | ±0% | 22,000 |
2022/11/07 | 2,901 | 2,923 | 2,875 | 2,905 | +7 | +0.2% | 14,300 |
2022/11/04 | 2,919 | 2,919 | 2,880 | 2,898 | -62 | -2.1% | 32,600 |
2022/11/02 | 2,961 | 2,986 | 2,921 | 2,960 | +29 | +1% | 31,500 |
2022/11/01 | 3,000 | 3,000 | 2,850 | 2,931 | -89 | -2.9% | 49,000 |
2022/10/31 | 3,020 | 3,055 | 3,000 | 3,020 | +49 | +1.6% | 54,200 |
2022/10/28 | 2,979 | 3,010 | 2,961 | 2,971 | -49 | -1.6% | 92,900 |
2022/10/27 | 3,010 | 3,020 | 2,993 | 3,020 | +20 | +0.7% | 25,800 |
551~
600
件表示中 / 3676件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 410,500円 | +7.1% | -35.0% | 2.92% | 33.94倍 | 0.95倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
キッセイ薬 | 359,000円 | +14.5% | -2.3% | 2.51% | 13.13倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
東和薬品 | 236,700円 | +15.0% | -7.3% | 2.96% | 7.77倍 | 0.73倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 213,300円 | +14.2% | +41.0% | 2.16% | 10.45倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
サンバイオ | 154,600円 | - | - | 0.00% | - | 71.61倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム